NCT02923869View on ClinicalTrials.gov

Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Recovery After Cleft Palate Surgery
Interventions
DRUG

Levobupivacaine

Children will receive 0.15 ml/kg of 0.2% Levobupivacaine through bilateral suprazygomatic MNB.

DRUG

Bupivacaine

Children will receive 0.15 ml/kg of 0.2% Bupivacaine through bilateral suprazygomatic MNB.

Trial Locations (1)

71515

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02923869 - Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery | Biotech Hunter | Biotech Hunter